Align Technology (ALGN) Jefferies Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Healthcare Conference 2026 summary
4 Jun, 2026Macro environment and business outlook
International markets are experiencing double-digit growth, especially in APAC, EMEA, and Latin America, while North America shows stability but faces retail-side pressure.
Guidance for the year includes 3%-4% revenue growth and a 100 basis point operating margin improvement, reflecting ongoing cost actions and productivity gains.
Sequential revenue growth from Q1 to Q2 is expected to be more modest (midpoint of 1%) due to prudent guidance amid ongoing macro uncertainty.
Cost actions and increased volume are driving operating margin leverage, with a 250 basis point improvement ex-FX in Q1.
The company feels well-positioned for the year, executing strategies despite an uncertain environment.
Product innovation and rollout
The comprehensive product with no refinements is being rolled out broadly, targeting orthodontists and DSOs, with full rollout expected by year-end.
This product is designed to compete with wires and brackets, offering price competitiveness and high gross margins due to fewer refinements.
Early adoption among DSOs has led to increased utilization, and similar trends are emerging among retail accounts.
Flexibility in product offerings, such as the 3-and-3 plan, allows doctors to choose service levels, supporting adoption.
Gross margins are equal to or better in DSOs compared to retail, with operational efficiencies contributing to higher operating margins.
Tools and programs to drive conversion
Financing programs like HFD and Smile Advance, offering low down payments and 0% APR, are helping drive patient conversion, with over 6,000 offices enrolled.
These programs benefit both patients (affordability) and doctors (upfront cash flow), with high acceptance rates and support from DSOs.
Adoption is faster in DSOs due to top-down implementation, but retail doctors are also being targeted with support and education.
Financing is more common among general dentists than orthodontists, but both segments are being addressed to drive conversion.
Visualization tools and active sales support help doctors convert interested patients into treatments.
Latest events from Align Technology
- International growth, product innovation, and digital adoption drive double-digit gains and margin expansion.ALGN
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - AI-powered digital workflows and 3D printing are transforming orthodontic care and patient engagement.ALGN
46th Annual William Blair Growth Stock Conference3 Jun 2026 - Innovation, international growth, and DSOs drive performance amid prudent financial guidance.ALGN
Stifel Jaws & Paws Conference 20262 Jun 2026 - Q1 2026 revenue up 6.2% to $1.04B, with record aligner volumes and $113M net income.ALGN
Q1 20266 May 2026 - Voting standard for Proposal 4 clarified; majority approval of shares present or represented required.ALGN
Proxy filing17 Apr 2026 - Record Q4 and FY2025 revenues, strong Clear Aligner and DSO growth, and positive 2026 outlook.ALGN
Q4 202517 Apr 2026 - Record revenues, robust governance, and enhanced shareholder rights highlight this year's proxy.ALGN
Proxy filing7 Apr 2026 - Virtual Annual Meeting to address director elections, compensation, auditor, and bylaw proposals.ALGN
Proxy filing7 Apr 2026 - Record revenues, robust governance, and enhanced shareholder rights highlight this year's proxy.ALGN
Proxy filing27 Mar 2026